Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids

Tel Aviv Sourasky Medical Center

Status: Unknown

Conditions: Osteoporosis

Treatments: Device: Dual energy X-ray absorptiometry

Study type: Interventional

Funder types: Other

Identifiers

NCT01246375

TASMC-10-SY-454-CTIL

Details and patient eligibility

About

The purpose of this research is to determine whether the prevalence of osteoporosis is greater in patients who suffer from Chronic obstructive pulmonary disease (COPD) or Asthma disease and uses inhaled steroids.

Enrollment: 20 estimated patients

Sex: Male

Ages: 60 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Man at the minimum age of 60 years.
2. Diagnosed with Chronic Obstructive Pulmonary disease (COPD) or Asthma disease.
3. Usage of the following corticosteroids at the minimal doses indicated, for at least 3 years:

Seretide 250/50 mcg Symbicort 320/9 mcg 5.No Diagnosis of thyroid irregularity 6.No diagnosis/treatment for Osteoporosis.

Exclusion criteria

1. Usage of systemic steroids more than once during the 12 months prior to the study.
2. Usage of systemic steroids during the month prior to the study.
3. Usage of inhaled steroids in order to treat any other disease except Chronic Obstructive Pulmonary Disease (COPD) or Asthma.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)